140 related articles for article (PubMed ID: 10826740)
21. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
[TBL] [Abstract][Full Text] [Related]
22. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
[TBL] [Abstract][Full Text] [Related]
23. Lipid apheresis, indications, and principles.
Winters JL
J Clin Apher; 2011; 26(5):269-75. PubMed ID: 21834078
[TBL] [Abstract][Full Text] [Related]
24. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
Zwiener RJ; Uauy R; Petruska ML; Huet BA
J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
[TBL] [Abstract][Full Text] [Related]
25. Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles.
Hovland A; Marcovina S; Hardersen R; Enebakk T; Mollnes TE; Lappegård KT
Transfus Apher Sci; 2012 Feb; 46(1):73-6. PubMed ID: 22206792
[TBL] [Abstract][Full Text] [Related]
26. Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992.
Gordon BR; Saal SD
Transfus Sci; 1993 Jul; 14(3):261-8. PubMed ID: 10146337
[No Abstract] [Full Text] [Related]
27. The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability.
Kroon AA; Demacker PN; Kleinveld HA; Stalenhoef AF
Atherosclerosis; 1999 Nov; 147(1):105-13. PubMed ID: 10525131
[TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kinetics.
Barrett PH; Parhofer KG
Metabolism; 1998 Apr; 47(4):478-83. PubMed ID: 9550549
[TBL] [Abstract][Full Text] [Related]
29. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
30. [Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].
Delplanque B; Emmerich J; Norol F; Jourdan D; Duedari N; Jacotot B
Ann Med Interne (Paris); 1988; 139 Suppl 1():80-2. PubMed ID: 2470282
[TBL] [Abstract][Full Text] [Related]
31. Acute changes in plasma levels of hepatocyte growth factor during low-density lipoprotein apheresis.
Kojima S; Shida M; Tanaka K; Takano H; Yokoyama H; Kuramochi M
Ther Apher; 2001 Feb; 5(1):2-6. PubMed ID: 11258604
[TBL] [Abstract][Full Text] [Related]
32. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels.
Bambauer R; Schiel R; Klinkmann J; Latza R
J Clin Apher; 1996; 11(2):78-80. PubMed ID: 8844436
[TBL] [Abstract][Full Text] [Related]
33. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
[TBL] [Abstract][Full Text] [Related]
34. LDL-apheresis as long-term treatment in severe hyperlipidemia using differing methods.
Bambauer R; Schiel R; Latza R; Schneidewind JM
ASAIO J; 1999; 45(5):408-12. PubMed ID: 10503616
[TBL] [Abstract][Full Text] [Related]
35. Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.
Masin V; Blaha M; Stransky P; Blaha V; Cermanova M; Maly R; Zajic J
Transfus Apher Sci; 2007 Feb; 36(1):39-45. PubMed ID: 17292673
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)-The Portuguese experience.
Ferreira L; Palma I; Bacelar C; Queirós JA; Madureira A; Oliveira JC; Ramos MH; Cardoso H
Transfus Apher Sci; 2018 Oct; 57(5):676-680. PubMed ID: 30287070
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia.
Otto C; Kern P; Bambauer R; Kallert S; Schwandt P; Parhofer KG
Artif Organs; 2003 Dec; 27(12):1116-22. PubMed ID: 14678426
[TBL] [Abstract][Full Text] [Related]
38. Low-density lipoprotein apheresis: principles and indications.
Winters JL
Semin Dial; 2012; 25(2):145-51. PubMed ID: 22277063
[TBL] [Abstract][Full Text] [Related]
39. Experience with low-density lipoprotein apheresis by polyclonal and monoclonal anti-apolipoprotein B antibodies and by dextran sulfate cellulose.
Riesen WF
Curr Stud Hematol Blood Transfus; 1990; (57):208-19. PubMed ID: 2272202
[No Abstract] [Full Text] [Related]
40. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG
Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
